This is not the most recent version of the article. View current version (8 JUL 2009)

Intervention Protocol

Adjuvant chemotherapy for early stage cervix cancer

  1. Daniela D Rosa1,*,
  2. Lídia RF Medeiros2,
  3. Mary C Bozzetti3,
  4. Maria I Edelweiss4,
  5. Paula R Pohlmann5,
  6. Airton T Stein6

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD005342

How to Cite

Rosa DD, Medeiros LRF, Bozzetti MC, Edelweiss MI, Pohlmann PR, Stein AT. Adjuvant chemotherapy for early stage cervix cancer (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005342. DOI: 10.1002/14651858.CD005342.

Author Information

  1. 1

    Hospital Femina - Grupo Hospitalar Conceicao, Porto Alegre, Rio Grande do Sul, Brazil

  2. 2

    Federal University of Rio Grande do Sul, Social Medicine/Epidemiology, Porto Alegre, Rio Grande do Sul, Brazil

  3. 3

    Faculty of Medicine at Federal University of Rio Grande do Sul, Social Medicine, Rio Grande do Sul, Brazil

  4. 4

    Faculty of Medicine at Federal University of Rio Grande do Sul, Pathology, Rio Grande do Sul, Brazil

  5. 5

    Faculty of Medicine at Federal University of Rio Grande do Sul, Medical Sciences, Rio Grande do Sul, Brazil

  6. 6

    Fundacao Faculdade Federal de Ciencias Medicas de Porto Algre, Department of Epidemiology, Porto Alegre, Brazil

*Daniela D Rosa, Hospital Femina - Grupo Hospitalar Conceicao, Dinarte Ribeiro 212/83, Porto Alegre, Rio Grande do Sul, 90570-150, Brazil. dornellesrosa@hotmail.com.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article.View current version (08 Jul 2009)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objectives of this review are to evaluate the impact of chemotherapy in the adjuvant treatment of early cervix cancer (stages IB1 - IIA). The main outcomes of interest are survival and recurrence rates.

The following issue will be addressed in this review:
Is adjuvant chemotherapy effective in reducing recurrence and improving survival in patients with IA2 - IIA early stage cervix cancer after radical hysterectomy or radiotherapy compared to radical hysterectomy alone, radiotherapy alone, or radical hysterectomy followed by radiotherapy alone.